Inspyr Broadens Intellectual Property Portfolio with New Patent Issued on Methods for Producing Cancer Compounds
20 oct. 2016 07h00 HE
|
Inspyr Therapeutics
WESTLAKE VILLAGE, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...
Inspyr Therapeutics Appoints Richard Buller, M.D., Ph.D. to Board of Directors
13 oct. 2016 07h00 HE
|
Inspyr Therapeutics
WESTLAKE VILLAGE, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...
Inspyr Therapeutics Appoints Claire Thom, Pharm.D. to Board of Directors
12 oct. 2016 07h00 HE
|
Inspyr Therapeutics
WESTLAKE VILLAGE, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...
Inspyr Therapeutics Strengthens Clinical Development Capabilities with Appointment of Michael Elliott as Vice President of Clinical Operations
11 oct. 2016 07h00 HE
|
Inspyr Therapeutics
WESTLAKE VILLAGE, Calif., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...